Medicine
Quelicin 200 mg/10 mL injection
Quelicin 200 mg/10 mL injection is a prescription medicine containing Succinylcholine for intramuscular, intravenous use, marketed by Hospira, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in refrigerator 2°C to 8°C (36°F to 46°F). The multiple-dose vials are…
Key facts
- Active ingredient (INN)
- Succinylcholine
- Brand
- Quelicin
- Strength
- 200 mg/10 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 25 vials of 10 mL
- Marketing authorisation holder
- Hospira
- Manufacturer
- Hospira
- Origin register
- US FDA, United States
- Storage
- Store in refrigerator 2°C to 8°C (36°F to 46°F). The multiple-dose vials are stable for up to 14 days at room temperature without significant loss of potency.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03AB01 Succinylcholine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 April 2005
- Identifiers
- RxCUI 1594589, 1594593DailyMed set ID fb08161e-7711-406d-e7b3-ea4515c07983NDC 0409-6629Application NDA008845
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 0409-6629-02 | Hospira | 30 April 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 20 August 1952 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Succinylcholine 200 mg/10 mL injection.
Other strengths and forms of Succinylcholine
Clinical summary
Succinylcholine is a depolarizing neuromuscular blocker indicated in adults and pediatric patients, among other approved uses. It is available as injection for intramuscular, intravenous and parenteral use. MedsAcross supplies Succinylcholine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SuccinylcholineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Anectine prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
Need Quelicin 200 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.